Caesarean section bleeding prevention study
Part of Women’s health & pregnancy clinical trials.
This trial tests a new method to prevent heavy bleeding during cesarean sections. It may help make the procedure safer for mothers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and scheduled for a cesarean section.
- The hospital where you deliver is participating in this study.
- You do not choose to opt out of the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This trial tests if giving a medication called misoprostol as a rectal suppository can help reduce bleeding during a planned cesarean section. If you are having a planned cesarean and are generally healthy, this study might be an option for you.
This trial compares two medications, carbetocin and misoprostol, to see which works better at preventing heavy bleeding (postpartum hemorrhage) after a vaginal delivery. It is for women who have one or more risk factors for heavy bleeding.
This trial tests if a set of medical steps (a care bundle) can reduce heavy bleeding after cesarean delivery. You might be eligible if you're having a C-section at a participating hospital.
This trial tests whether giving a specific combination of three medicines during a planned c-section is better than one medicine alone for preventing postpartum hemorrhage (heavy bleeding after birth).
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.